Literature DB >> 311510

Macrophage requirement for the in vitro response to an insolubilized T-independent antigen.

H Duclos, P Galanaud, M C Maillot, M C Crevon, J Dormont.   

Abstract

The role of macrophages in the in vitro response of mouse spleen cells to the insolubilized, T-independent antigen trinitrophenylated polyacrylamide (TNP-PAA) is demonstrated by the following points. The response is abolished by filtration on Sephadex G-10 and can be restored by the addition of splenic adherent cells, deficient in either B or T cells, or by 2-mercaptoethanol (2ME). It is suppressed upon elimination of phagocytic cells by silica, and restored by 2-ME. 2-ME can restore a normal response from zero, in cultures depleted of both adherent and phagocytic cells, and is efficient in the absence of mature T cells. Experiments in microcultures show that large numbers of macrophages can stimulate a supra-optimal response from B cells. This response is only obtained in the presence of the antigen, and is specific for TNP. These results show that microphages, probably by their polyclonal B-cell activator (PBA) property, play a role in the specific response to TNP-PAA. This prompts us to discuss the respective roles in the B-cell response of this PBA activity and of the interaction of the antigen with the specific B-cell receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311510     DOI: 10.1111/j.1365-3083.1979.tb02718.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins.

Authors:  J Van Ness; U K Laemmli; D E Pettijohn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

2.  Xid mouse lymphocytes respond to TI-2 antigens when co-stimulated by TI-1 antigens or lymphokines.

Authors:  J Couderc; M Février; C Duquenne; P Sourbier; P Liacopoulos
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.